Loading page…
Healthcare
Centene Corporation holds an AlphaScore of 55/100 in the Healthcare sector as of October 11, 2026. The company exhibits a strong revenue growth metric of 19.44%, alongside a negative return on equity (roe) of -33.45% indicating a notable fundamental risk. Additional metrics include a net margin of -3.43% and a forward pe of 12.22. At a price of $65.36 and a market capitalization of $32.29 billion, Centene displays solid momentum with an 81 sub-score despite its negative profitability metrics. The firm does not currently pay a dividend. Evidence is limited to the provided snapshot data for this single record.
Written 11/10/2026, 00:32:44 UTC · Snapshot 11/10/2026